April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Tesla: Rebound Signals Strength Amid Economic Shifts
3M: Evaluating Challenges to Portfolio Resilience
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Second Sight Medical Products (EYES) stock forecast for 2025
Updated: April 21, 2025 (08:23)
Sector: HealthcareThe share price of Second Sight Medical Products, Inc. (EYES) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Second Sight Medical Products stocks, the 50-day moving average is the support level today.
For Second Sight Medical Products stocks, the 200-day moving average is the support level today.
Are you interested in Second Sight Medical Products, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Second Sight Medical Products stock price in 2025. How much will one Second Sight Medical Products share be worth in 2025? Is it worth taking profit / loss on EYES stock now or waiting? What are analysts' forecasts for Second Sight Medical Products stock?
We forecast Second Sight Medical Products stock performance using neural networks based on historical data on EYES stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Second Sight Medical Products, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Second Sight Medical Products analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Second Sight Medical Products, Inc. stock
The chart below shows the historical price of Second Sight Medical Products stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EYES stock price can be found in the table below.
Second Sight Medical Products Inc designs, manufactures and markets implantable prostheses to create an artificial form of useful vision for the blind. Argus II System’s product treats external retinal degenerations such as retinitis pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include an implant and external components. Geographically, the company operates in the United States, Italy, China, and most of its revenue comes from the United States.
Second Sight Medical Products (EYES) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May | 4.92 | 4.24 | 5.36 | 20.84 % |
| Jun | 5.87 | 5.38 | 6.12 | 12.09 % |
| Jul | 5.40 | 5.08 | 6.31 | 19.60 % |
| Aug | 4.98 | 4.49 | 5.19 | 13.50 % |
| Sep | 4.18 | 3.61 | 4.81 | 24.99 % |
| Oct | 4.10 | 3.63 | 4.50 | 19.15 % |
| Nov | 4.38 | 4.08 | 4.71 | 13.30 % |
| Dec | 4.83 | 4.42 | 5.04 | 12.27 % |
Second Sight Medical Products information and performance
N/A
Market capitalization of the Second Sight Medical Products, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYES shares in the company outstanding by the market price of one share.
EBITDA of Second Sight Medical Products is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Second Sight Medical Products price target for 2025 by month
Target values for the price of one Second Sight Medical Products share for May 2025.
In May, the Positive dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 20.842% volatility is expected.
Pessimistic target level: 4.24
Optimistic target level: 5.36
Target values for the price of one Second Sight Medical Products share for Jun 2025.
In Jun, the Positive dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 12.092% volatility is expected.
Pessimistic target level: 5.38
Optimistic target level: 6.12
Target values for the price of one Second Sight Medical Products share for Jul 2025.
In Jul, the Negative dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 19.598% volatility is expected.
Pessimistic target level: 5.08
Optimistic target level: 6.31
Target values for the price of one Second Sight Medical Products share for Aug 2025.
In Aug, the Negative dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 13.503% volatility is expected.
Pessimistic target level: 4.49
Optimistic target level: 5.19
Target values for the price of one Second Sight Medical Products share for Sep 2025.
In Sep, the Negative dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 24.991% volatility is expected.
Pessimistic target level: 3.61
Optimistic target level: 4.81
Target values for the price of one Second Sight Medical Products share for Oct 2025.
In Oct, the Negative dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 19.150% volatility is expected.
Pessimistic target level: 3.63
Optimistic target level: 4.50
Target values for the price of one Second Sight Medical Products share for Nov 2025.
In Nov, the Positive dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 13.302% volatility is expected.
Pessimistic target level: 4.08
Optimistic target level: 4.71
Target values for the price of one Second Sight Medical Products share for Dec 2025.
In Dec, the Positive dynamics for Second Sight Medical Products, Inc. shares will prevail with possible monthly volatility of 12.269% volatility is expected.
Pessimistic target level: 4.42
Optimistic target level: 5.04
Related stocks from Healthcare sector
